Can extra care after transplant help older patients live better?

NCT ID NCT03870750

Terminated Disease control Sponsor: Fred Hutchinson Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested two extra care programs—supportive palliative care and clinical management of other health issues—for older or frail patients who had a donor stem cell transplant. The goal was to see if these programs could improve quality of life and survival compared to standard care. The trial was stopped early, so we don't have clear answers yet.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Supportive palliative care and clinical management (exercise, stress reduction, medication management, dietary advice)
What this could lead to: If successful, this could lead to better quality of life and longer survival for older or frail patients after a stem cell transplant.
What could go wrong: The trial was terminated early, so results are limited. The approaches are supportive and may not change disease outcomes significantly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hematologic disorder hematopoietic and lymphoid cell neoplasm hematopoietic and lymphoid system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM NON-NEOPLASTIC HEMATOLOGIC AND LYMPHOCYTIC DISORDER

Contacts and locations

Locations

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center

Houston, Texas, 77030, United States
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center

Cleveland, Ohio, 44195, United States
Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, 98109, United States
Mayo Clinic

Rochester, Minnesota, 55905, United States
Northwell Health Cancer Institute

New Hyde Park, New York, 11042, United States
Oregon Health and Science University

Portland, Oregon, 97239, United States
Stanford Cancer Institute Palo Alto

Palo Alto, California, 94304, United States
University of California San Francisco

San Francisco, California, 94143, United States
University of Minnesota/Masonic Cancer Center

Minneapolis, Minnesota, 55455, United States
Vanderbilt University

Nashville, Tennessee, 37232, United States
Wayne State University/Karmanos Cancer Institute

Detroit, Michigan, 48201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.